Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged 60 or older
- People who have a CAIDE dementia risk score higher than 8 (this is a score based on factors like age, lifestyle, and health history that estimates dementia risk — the trial site can confirm this score)
- People who do not have significant memory or thinking problems, as measured by a specific cognitive test called the Addenbrooke's Cognitive Examination-Revised
- People who do not have physical disabilities that would prevent them from taking part in the study activities
- People who are willing and able to complete all study activities over a 12-week period
Who may not be able to join:
- People who have already been diagnosed with mild cognitive impairment or dementia
- People who have a history of a neurological event (such as a stroke or brain injury) that may have affected their current thinking or memory
- People who have a severe psychiatric disorder (note: mild depression or anxiety symptoms do not appear to prevent participation — confirm with trial site)
- People who are unable to travel to the location where sessions are held (confirm with trial site, as online participation options may exist for some groups)
- People who are unable to read or write
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +351962779695
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognitive status composite; Functionality status; Blood biomarkers of neural damage; Cognitive status composite; Functionality status; Cognitive status composite; Functionality status
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.